Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.
Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Catapano AL. Ferrari R, et al. Among authors: filardi pp. Eur Heart J Suppl. 2016 Apr 12;18(Suppl C):C2-C12. doi: 10.1093/eurheartj/suw009. Eur Heart J Suppl. 2016. PMID: 28533705
[No title available]
[No authors listed] [No authors listed] PMID: 39661530
Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry).
Palazzuoli A, Dini FL, Agostoni P, Cartocci A, Morrone F, Tricarico L, Correale M, Mercurio V, Nodari S, Severino P, Badagliacca R, Barillà F, Paolillo S, Filardi PP; Italian Heart Failure Study Group, Italian Society of Cardiology. Palazzuoli A, et al. Among authors: filardi pp. J Cardiovasc Med (Hagerstown). 2024 Jun 1;25(6):457-465. doi: 10.2459/JCM.0000000000001623. Epub 2024 Apr 26. J Cardiovasc Med (Hagerstown). 2024. PMID: 38652523
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases.
Imazio M, Collini V, Aimo A, Autore C, Bauce B, Biagini E, Cappelli F, Castelletti S, D'Ascenzi F, De Gregorio C, Limongelli G, Marzo F, Merlo M, Musumeci B, Paolillo S, Tini G, Pedrinelli R, Filardi PP, Sinagra G. Imazio M, et al. Among authors: filardi pp. J Cardiovasc Med (Hagerstown). 2025 Jan 1;26(1):29-37. doi: 10.2459/JCM.0000000000001684. Epub 2024 Nov 25. J Cardiovasc Med (Hagerstown). 2025. PMID: 39661544
A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study.
Grilli G, Salvioni E, Moscucci F, Bonomi A, Sinagra G, Schaeffer M, Campodonico J, Mapelli M, Rossi M, Carriere C, Emdin M, Piepoli M, Paolillo S, Senni M, Passino C, Apostolo A, Re F, Santolamazza C, Magrì D, Lombardi CM, Corrà U, Raimondo R, Cittadini A, Iorio A, Salzano A, Lagioia R, Vignati C, Badagliacca R, Passantino A, Filardi PP, Correale M, Perna E, Girola D, Metra M, Cattadori G, Guazzi M, Limongelli G, Parati G, De Martino F, Matassini MV, Bandera F, Bussotti M, Scardovi AB, Sciomer S, Agostoni P; MECKI Score Research Group. Grilli G, et al. Among authors: filardi pp. Front Cardiovasc Med. 2024 Jul 3;11:1390544. doi: 10.3389/fcvm.2024.1390544. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39022621 Free PMC article.
Innovations in medical therapy of heart failure with reduced ejection fraction.
Mercurio V, Ambrosio G, Correale M, Dini FL, Ghio S, Nodari S, Palazzuoli A, Ruocco G, Pedrinelli R, Mercuro G, Filardi PP, Indolfi C, Agostoni P, Tocchetti CG, Paolillo S. Mercurio V, et al. Among authors: filardi pp. J Cardiovasc Med (Hagerstown). 2023 Apr 1;24(Suppl 1):e47-e54. doi: 10.2459/JCM.0000000000001413. Epub 2022 Dec 15. J Cardiovasc Med (Hagerstown). 2023. PMID: 36729606 Review.
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
Belmonte M, Foà A, Paolisso P, Bergamaschi L, Gallinoro E, Polimeni A, Scarsini R, Muscoli S, Amicone S, De Vita A, Villano A, Angeli F, Armillotta M, Sucato V, Tremamunno S, Morrone D, Indolfi C, Filardi PP, Ribichini F, Lanza GA, Chieffo A, Barbato E, Pizzi C; Coronary Physiopathology and Microcirculation Working Group of the Italian Society of Cardiology (SIC). Belmonte M, et al. Among authors: filardi pp. Prog Cardiovasc Dis. 2024 Nov-Dec;87:73-82. doi: 10.1016/j.pcad.2024.10.006. Epub 2024 Oct 22. Prog Cardiovasc Dis. 2024. PMID: 39447854 Review.
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
European Association for Cardiovascular Prevention & Rehabilitation; Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. European Association for Cardiovascular Prevention & Rehabilitation, et al. Among authors: filardi pp. Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158. Epub 2011 Jun 28. Eur Heart J. 2011. PMID: 21712404 Free article.
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS). Catapano AL, et al. Among authors: filardi pp. Atherosclerosis. 2011 Jul;217(1):3-46. doi: 10.1016/j.atherosclerosis.2011.06.028. Atherosclerosis. 2011. PMID: 21882396 Review. No abstract available.
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.
Aguiar C, Alegria E, Bonadonna RC, Catapano AL, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Ferrari R. Aguiar C, et al. Among authors: filardi pp. Atheroscler Suppl. 2015 Sep;19:1-12. doi: 10.1016/S1567-5688(15)30001-5. Atheroscler Suppl. 2015. PMID: 26315511
136 results